Disorders which frequently overlap with irritable bowel syndrome: Can a shared neurobiology explain their frequent association?

Primary Psychiatry

Volumn 14, Issue 4, 2007, Pages 69-73

  Goddard, Emily R ^a,c   Barth, Kelly S ^a,c   Lydiard, R Bruce ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Southeast Health Consultants LLC   (United States)

^c MUSC Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL GLAND; COMORBIDITY; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; IRRITABLE COLON; MENTAL DISEASE; MOOD DISORDER; NEUROBIOLOGY; PATHOPHYSIOLOGY; PSYCHOMOTOR DISORDER; PSYCHOSOMATIC DISORDER; REVIEW;

EID: 34248192843     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(6):2108-2131.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480-1491. Erratum in: Gastroenterology. 2006;131(2):688.
3. Chang L, Toner BB, Fukudo S, et al. Gender, age, society culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130(5):1435-1446.
4. Palsson OS, Whitehead WE. Comorbidity associated with irritable bowel syndrome. Psychiatr Ann. 2005;35(4):320-324.
5. Chang L. Neuroendocrine and neuroimmune markers in IBS, pathophysiology or epiphenomenon. Gastroenterology. 2006;130(2):596-600.
6. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377-1390.
7. Drossman DA, Li Z, Leserman J, Toomey TC, Hu YJ. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology. 1996;110(4):999-1007.
8. Charmandari A, Kino T, Chrousos G. Glucocorticoids and their actions: an introduction. Ann N Y Acad Sci. 2004;1024(11):1-8.
9. Tan S, Tillisch K, Mayer E. Functional somatic syndromes: emerging biomedical models and traditional chinese medicine. Evid Based Complement Alternat Med. 2004;1(1):35-40.
10. Whitehead WE, Palsson O, Jones KR. Systematic review of comorbidity of irritable bowel syndrome other disorders: what are the causes and implications? Gastroenterology. 2002;122(4) 1140-1156.
11. Sperber AD, Atzmon Y, Neumann L, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol. 1999;94(12):3541-3546.
12. Chang L, Mayer EA, Johnson T, FitzGerald LZ, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain. 2000;84(2-3):297-307.
13. Williams RE, Hartmann KE, Sandler RS, Miller WC, Savitz LA, Steege JF. Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol. 2005;192(3):761-767.
14. Longstreth GF. Irritable bowel syndrome and chronic pelvic pain. Obstet Gynecol Surv. 1994;49(7):505-507.
15. Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion. 2000;62(1):66-72.
16. Palsson O, Drossman DA. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin N Am. 2005;34(2):281-303.
17. Leserman J. Association of sexual and physical abuse with functional gastrointestinal and pelvic pain. Primary Psychiatry. 2007;14(4):58-63.
18. Simon GE, VonKorff M. Somatization and psychiatric disorders in NIMH Epidemiologic Catchment Area study. Am J Psychiatry. 1991;148(11):1494- 1500.
19. Roy-Byrne PP, Wagner AW, Schraufnagel TJ. Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry. 2005;66(suppl 4):16-22.
20. Lydiard RB. Increased prevalence of functional gastrointestinal disorders in panic disorder: clinical and theoretical implications. CNS Spectr. 2005;10(11):899-908.
21. Masand PS, Keuthen NJ, Gupta S, Virk S, Yu-Siao B, Kaplan D. Prevalence of irritable bowel syndrome in obsessive-compulsive disorder. CNS Spectr. 2006;11(1):21-25.
22. Masand PS, Kaplan DS, Gupta S, Bhandary AN. Irritable bowel syndrome and dysthymia. Is there a relationship? Psychosomatics. 1997;38(1):63-69.
23. Masand PS, Kaplan DS, Gupta S, et al. Major depression and irritable bowel syndrome: is there a relationship? J Clin Psychiatry. 1995;56(8):363-367.
24. Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2(12):1064-1068.
25. Hudson JI, Mangweth B, Pope HG Jr, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003:60(2):170-177.
26. Hudson JI, Arnold LM, Keck PE Jr, Auchenbach MB, Pope HG Jr. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry. 2004;56(11):884-891.
27. Vierck CJ Jr. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain. 2006;124(3)242-263.
28. Demitrack MA, Crofford U. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci. 1998;840:684-697.
29. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003;160(9):1554-1565.
30. Heim C, Ehlert U, Hanker JP, Hellhammer DH. Psychological and endocrine correlates of chronic pelvic pain associated with adhesions. J Psychosom Obstet Gynaecol. 1999;20(1)11-20.
31. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med. 2003;35(1):2-11.
32. Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 2005;135(3):650-678.
33. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl). 2003;170(4):429-433.
34. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5(4);401-412.
35. Jarcho JM, Mayer EA. Stress and irritable bowel syndrome. Primary Psychiatry. 2007;14(4):74-78.
36. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med. 2002;64(1):15-28.
37. Lydiard RB. Psychopharmacology in the treatment of irritable bowel syndrome. Primary Psychiatry. 2007;14(4):40-42,45-49.